Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adagio Therapeutics (ADGI)
NASDAQ:ADGI
Adagio Therapeutics (ADGI) Financial Statements
0 Followers
Adagio Therapeutics Financial Overview
| Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -51.75M | $ -100.74M | $ -83.09M | $ -56.42M | $ -42.19M |
| EBITDA | $ -51.61M | $ -100.66M | $ -83.09M | $ -56.42M | $ -42.19M |
| Net Income Common Stockholders | $ -50.99M | $ -100.67M | $ -83.04M | $ -60.38M | $ -44.67M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 91.25M | $ 392.51M | $ 474.88M | $ 532.22M | $ 591.42M |
| Total Assets | $ 484.61M | $ 556.27M | $ 620.09M | $ 686.27M | $ 397.99M |
| Total Debt | $ 1.66M | $ 2.86M | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -89.59M | $ -389.65M | $ -474.88M | $ -532.22M | $ -591.42M |
| Total Liabilities | $ 69.77M | $ 96.88M | $ 62.07M | $ 53.06M | $ 542.62M |
| Stockholders Equity | $ 414.84M | $ 459.39M | $ 558.02M | $ 633.21M | $ -144.62M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -57.41M | $ -59.05M | $ -73.30M | $ -54.21M | $ -33.57M |
| Operating Cash Flow | $ -57.39M | $ -59.05M | $ -73.21M | $ -54.21M | $ -33.57M |
| Investing Cash Flow | $ -17.00K | $ 49.00M | $ 137.92M | - | - |
| Financing Cash Flow | $ 74.00K | $ 45.00K | $ -749.00K | $ 328.60M | $ 334.83M |
Adagio Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.